Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 18/20 | 0.72 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.38 |
| ▸ | CPT1A | P50416 | 1/20 | 0.38 |
| ▸ | CPT1B | Q92523 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1370558 | 0.92 | PTGDR2 (0.70) | PTGDR2CYP2C9 | |
| SCHEMBL1371698 | 0.91 | PTGDR2 (0.71) | PTGDR2 | |
| SCHEMBL1370491 | 0.91 | PTGDR2 (0.69) | PTGDR2CYP2C9 | |
| SCHEMBL1369903 | 0.88 | PTGDR2 (0.69) | PTGDR2 | |
| SCHEMBL3712213 | 0.84 | PTGDR2 (1.00) | PTGDR2CYP2C9 | |
| SCHEMBL1370252 | 0.84 | PTGDR2 (0.70) | PTGDR2 | |
| SCHEMBL1369415 | 0.83 | PTGDR2 (0.73) | PTGDR2 | |
| SCHEMBL12146136 | 0.81 | PTGDR2 (0.82) | PTGDR2CYP2C9 | |
| SCHEMBL1369403 | 0.78 | PTGDR2 (0.64) | PTGDR2 | |
| SCHEMBL1370082 | 0.76 | PTGDR2 (1.00) | PTGDR2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8273769-B2 | Phenoxy acetic acid derivatives | MERCK SERONO SA (CH) | 2012-09-25 | — | — | US | disclosed |
| US-20110288066-A1 | PHENOXY ACETIC ACID DERIVATIVES | MERCK SERONO S.A. (CH) | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288066-A1 | PHENOXY ACETIC ACID DERIVATIVES | HRH2, HRH1, HRH3 | PTGDR2 51/4885CYP2C9 2830/4885HSP90AA1 1429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.